What is Arima Genomics?
Arima Genomics, Inc. operates at the intersection of advanced molecular biology and data science, providing researchers with unparalleled access to the sequence and structural organization of genomes. By utilizing proprietary 3D genomics technologies, the company enables a deeper understanding of genome biology, which is essential for breakthroughs in human health and precision medicine. Their platform serves as a foundational tool for academic and clinical institutions aiming to map complex genomic architectures with high resolution and accuracy.
How much funding has Arima Genomics raised?
Arima Genomics has raised a total of $7.8M across 3 funding rounds:
Debt
$350K
Debt
$411K
Series B
$7M
Debt (2020): $350K with participation from PPP
Debt (2021): $411K led by PPP
Series B (2022): $7M supported by Agile Technologies, Ladder Ventures, Tech Coast Angels, GENETRON HEALTH, and Hiaqua Investments
Key Investors in Arima Genomics
Agile Technologies
A technology service firm focused on building durable, long-term business results through specialized consulting and process optimization.
GENETRON HEALTH
A leading precision oncology platform specializing in cancer molecular profiling and advanced data science applications for clinical treatment.
Tech Coast Angels
A prominent investment group known for supporting early-stage and growth-oriented technology ventures with strategic capital and mentorship.
What's next for Arima Genomics?
With the recent influx of capital, Arima Genomics is poised to scale its operational capacity and enhance its technological infrastructure. The strategic focus will likely shift toward broadening the commercial application of its 3D genomics tools, fostering partnerships with global biopharmaceutical entities, and refining its diagnostic capabilities. As the company transitions into this next phase of development, the emphasis will remain on maintaining its competitive advantage in the high-growth genomics market while driving innovation in structural genome analysis.
See full Arima Genomics company page
